Non - muscle - invasive bladder cancer (NMIBC)
搜索文档
Relmada Therapeutics(RLMD) - 2025 Q3 - Earnings Call Transcript
2025-11-14 06:30
Relmada Therapeutics (NasdaqGS:RLMD) Q3 2025 Earnings Call November 13, 2025 04:30 PM ET Speaker4Good afternoon and welcome to Relmada Therapeutics third quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the prepared remarks, we will conduct a question-and-answer session. To ask a question, please press star and one. As a reminder, this conference call is being recorded and will be available for replay on the Relmada website. I would now like to turn the ...